Differences in Managing Anticoagulants and Antiplatelets for Gastrointestinal Endoscopy between East and West

Sun-Young Lee1

  • 1Department of Internal Medicine, Konkuk University School of Medicine, 4-12 Hwayang-dong, Gwangjin-gu, Seoul 143-729, South Korea.

Gastroenterology Research
|December 14, 2016
PubMed

Insights

Managing anticoagulation and antiplatelet medications for gastrointestinal endoscopy requires different approaches for Eastern and Western patients. This is due to variations in drug metabolism, bleeding risk, and embolism types.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Cardiology

Background:

  • Managing anticoagulation and antiplatelet medications during gastrointestinal (GI) endoscopic procedures presents a critical balance between bleeding and thromboembolic risks.
  • Current Western guidelines for managing these medications in GI endoscopy may not be universally applicable, potentially leading to adverse events in Eastern populations.

Approach:

  • This analysis considers differences in drug metabolism, hemorrhage risk, and thromboembolic patterns between Eastern and Western patients undergoing GI endoscopy.
  • Investigates the predisposition of Asian populations to cerebrovascular events versus Western populations' tendency towards cardiovascular events during drug cessation.

Key Points:

  • Eastern patients exhibit greater body weight-normalized plasma unbound clearance of drugs, impacting medication management.
  • Adherence to Western guidelines by Eastern endoscopists may contribute to higher rates of massive bleeding.
  • Distinct management strategies are necessary, accounting for ethnic variations in drug metabolism and embolism risks.

Conclusions:

  • A one-size-fits-all approach to managing anticoagulation and antiplatelet therapy in GI endoscopy is inadequate.
  • Tailored management protocols are essential for GI endoscopy patients on these medications, considering East-West differences in metabolism, bleeding, and thromboembolism.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
433
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
707
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
562